Aquestive Therapeutics, Inc. AQST Asset retirement obligations
Asset retirement obligations at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetRetirementObligation.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s asset retirement obligations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s asset retirement obligations?
- Aquestive Therapeutics, Inc. (AQST) reported asset retirement obligations of $2.07M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s asset retirement obligations changed year-over-year?
- Aquestive Therapeutics, Inc.'s asset retirement obligations increased by 1.3% year-over-year, from $2.05M to $2.07M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s asset retirement obligations?
- Over 3 years (2022 to 2025), Aquestive Therapeutics, Inc.'s asset retirement obligations has grown at a 1.3% compound annual growth rate (CAGR), from $1.99M to $2.07M.
- What does asset retirement obligations mean?
- Estimated costs to dismantle, remove, and restore assets at the end of their useful lives — nuclear decommissioning, mine reclamation, oil well plugging.